Literature DB >> 7562374

Low and high melatonin excretors among healthy individuals.

J D Bergiannaki1, C R Soldatos, T J Paparrigopoulos, M Syrengelas, C N Stefanis.   

Abstract

To meet the need of establishing firm normative data regarding the secretion/excretion of human melatonin, nighttime urinary melatonin of 16 healthy volunteers was measured in samples collected monthly over a period of 1 year. Low melatonin excretors (N = 8) were distinguished from high melatonin excretors (N = 8), based on a cut-off mean melatonin value of 0.25 nmol/l. There was no overlap in any of the monthly melatonin values between the two groups, while their annual rhythms of melatonin excretion were not different in shape. Since no obvious factors (age, sex, height, weight, etc.) were responsible for the observed differences, the distinction between low and high nocturnal excretion and by inference secretion of melatonin most likely reflects genetically determined variable levels of the noradrenergic secretory drive and/or variable N-acetyltransferase/hydroxyindole-O-methyltransferase enzymatic activity during the night.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562374     DOI: 10.1111/j.1600-079x.1995.tb00155.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  16 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  EEG sleep spectra in older adults across all circadian phases during NREM sleep.

Authors:  Mirjam Münch; Edward J Silva; Joseph M Ronda; Charles A Czeisler; Jeanne F Duffy
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

3.  Seasonal pattern of melatonin excretion in humans: relationship to daylength variation rate and geomagnetic field fluctuations.

Authors:  T J Paparrigopoulos; C N Stefanis
Journal:  Experientia       Date:  1996-03-15

4.  Microstructural analysis of pineal volume using trueFISP imaging.

Authors:  Jan M Bumb; Marc A Brockmann; Christoph Groden; Ingo Nolte
Journal:  World J Radiol       Date:  2013-04-28

5.  Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men.

Authors:  Lara G Sigurdardottir; Sarah C Markt; Sigurdur Sigurdsson; Thor Aspelund; Katja Fall; Eva Schernhammer; Jennifer R Rider; Lenore Launer; Tamara Harris; Meir J Stampfer; Vilmundur Gudnason; Charles A Czeisler; Steven W Lockley; Unnur A Valdimarsdottir; Lorelei A Mucci
Journal:  J Biol Rhythms       Date:  2016-07-22       Impact factor: 3.182

6.  Contribution of the daily melatonin profile to diagnosis of tumors of the pineal region.

Authors:  José Leston; Carmine Mottolese; Jacques Champier; Anne Jouvet; Jocelyne Brun; Marc Sindou; Guy Chazot; Bruno Claustrat; Michelle Fèvre-Montange
Journal:  J Neurooncol       Date:  2009-01-25       Impact factor: 4.130

7.  Light and darkness fail to regulate melatonin release in critically ill humans.

Authors:  Boris Perras; Markus Meier; Christoph Dodt
Journal:  Intensive Care Med       Date:  2007-07-04       Impact factor: 17.440

8.  Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model.

Authors:  Sergio D Paredes; Carmen Barriga; Russel J Reiter; Ana B Rodríguez
Journal:  Int J Tryptophan Res       Date:  2009-01-14

9.  Melatonin in mitochondrial dysfunction and related disorders.

Authors:  Venkatramanujam Srinivasan; D Warren Spence; Seithikurippu R Pandi-Perumal; Gregory M Brown; Daniel P Cardinali
Journal:  Int J Alzheimers Dis       Date:  2011-05-04

Review 10.  Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders.

Authors:  Lindsay M Melhuish Beaupre; Gregory M Brown; Vanessa F Gonçalves; James L Kennedy
Journal:  Transl Psychiatry       Date:  2021-06-02       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.